[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100641608":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":32,"centralContacts":33,"locations":40,"responsibleParty":59,"collaborators":32,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":32,"eligibilityCriteria":69,"healthyVolunteers":65,"sex":70,"minAge":71,"maxAge":72,"enrollmentInfo":73,"targetDuration":32,"studyType":76,"phases":77,"briefSummary":79,"conditions":80,"keywords":83,"overallStatus":43,"whyStopped":32,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"subtransverse interligamentary plane block","EXPERIMENTAL","Patients will receive ultrasound-guided subtransverse interligamentary plane block with local anesthetic mixture (20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml))",[13],"Procedure: Subtransverse interligamentary plane block (STIL)",{"label":15,"type":16,"description":17,"interventionNames":18},"Thoracic paravertebral block","ACTIVE_COMPARATOR","Patients will receive ultrasound- guided thoracic paravertebral block with local anesthetic mixture (20 mL 0.25% bupivacaine, 100 micrograms of fentanyl (2ml))",[19],"Procedure: Thoracic paravertebral block (TPVB)",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Subtransverse interligamentary plane block (STIL)","Patients will receieve u;trasound guided subtransverse interligamentary plane block",[9],[27],"Arm 1",{"type":22,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"Thoracic paravertebral block (TPVB)","Patients will receieve ultrasound guided thoracic paravertebral block",[15],null,[34],{"name":35,"role":36,"phone":37,"phoneExt":38,"email":39},"Mai Salah Salem, MD anesthesia, SIC","CONTACT","01061107658","002","mai.salah@med.tanta.edu.eg",[41,55],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":32},"Tanta university hospital","RECRUITING","Tanta","Gharbia Governorate","31527","Egypt","EG",{"type":50,"coordinates":51},"Point",[52,53],31.00192,30.78847,{"lat":53,"lon":52},{"facility":42,"status":43,"city":44,"state":32,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":56,"geoPoint":58,"contacts":32},{"type":50,"coordinates":57},[52,53],{"lat":53,"lon":52},{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"PRINCIPAL_INVESTIGATOR","Mai Salah Salem","lecturer of anesthesia, SIC and pain medicine","100641608","subtransverse-interligamentary-block-versus-paravertebral-block-for-quality-of-recovery-after-mastectomy-100641608",false,"NCT07647367","Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Mastectomy","Ultrasound-Guided Subtransverse Interligamentary Plane Block Versus Thoracic Paravertebral Block for Quality of Recovery After Modified Radical Mastectomy: A Randomized Non-Inferiority Trial","Inclusion Criteria:\n\n* Adult female patients aged 18 to 65 years with American Society of Anesthesiologists (ASA) Physical Status I - III, who were scheduled for unilateral MRM surgery under general anesthesia and able to understand and complete the QoR-15 questionnaire\n\nExclusion Criteria:\n\n* • Patients declined to participate in the trial.\n\n  * History of allergy to the used local anesthetic (LA) drugs.\n  * Patients with cutaneous lesions at the needle entry point.\n  * Coagulopathy or current anticoagulant therapy contraindicating regional block.\n  * Patients with severe hepatic, renal, cardiac, or respiratory disease.\n  * Psychiatric or cognitive disorder interfering with QoR-15 assessment\n  * Chronic opioid use or chronic pain syndrome.\n  * Failed block.\n  * Morbid obesity (body mass index \\>40 kg\u002Fm2)\n  * Intraoperative major complications requiring postoperative ICU admission.\n  * Pregnancy","FEMALE","18 Years","65 Years",{"count":74,"type":75},60,"ESTIMATED","INTERVENTIONAL",[78],"NA","This prospective randomized controlled double blinded non-inferiority study will be carried out in Tanta University Hospitals for duration of 6 months from June 2026 to December 2026 on 60 female patients scheduled for unilatral modified radical mastectomy under general anesthesia.",[81,82],"Quality of Recovery (QoR-15)","Modified Radical Mastectomy",[9,84,85],"modified radical mastectomy","quality of recovery","2026-08-02",{"date":88,"type":89},"2026-08-04","ACTUAL",{"date":91,"type":89},"2026-06-20",{"date":93,"type":75},"2027-01",{"name":5,"class":6},2]